WAT
Waters CorporationNYSEHealthcare$304.24+1.45%ClosedMarket Cap: $18.11B
As of 2026-04-06
Valuation
P/E (TTM)
28.17
PEG
37.48
P/B
7.07
P/S
5.72
EV/EBITDA
18.46
DCF Value
$252.70
FCF Yield
3.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
58.9%
Operating Margin
26.6%
Net Margin
20.3%
ROE
28.5%
ROA
20.2%
ROIC
14.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $932.4M | 59.8% | $310.6M | $225.2M | $3.77 | — |
| FY 2025 | $3.17B | 57.8% | $893.2M | $642.6M | $10.76 | — |
| Q3 2025 | $799.9M | 59.0% | $192.1M | $148.9M | $2.50 | — |
| Q2 2025 | $771.3M | 58.3% | $188.2M | $147.1M | $2.47 | — |
| Q1 2025 | $661.7M | 58.2% | $151.7M | $121.4M | $2.03 | — |
| Q4 2024 | $872.7M | 60.1% | $292.3M | $231.4M | $3.88 | — |
| FY 2024 | $2.96B | 59.4% | $826.4M | $637.8M | $10.71 | — |
| Q3 2024 | $740.3M | 59.3% | $211.1M | $161.5M | $2.71 | — |
| Q2 2024 | $708.5M | 59.3% | $189.1M | $142.7M | $2.40 | — |
| Q1 2024 | $636.8M | 58.9% | $133.8M | $102.2M | $1.72 | — |
| Q4 2023 | $819.5M | 61.2% | $264.2M | $216.2M | $3.65 | — |
| FY 2023 | $2.96B | 59.6% | $817.7M | $642.2M | $10.84 | — |